Disclaimer - By publishing this information on this Web site, the Boston, Massachusetts law firm of Altman & Altman LLP is not claiming to represent any clients or cases mentioned here. The content provided is designed to inform readers and is not intended as legal advice.

Androgel, Axiron Users to File Suit against Manufacturer over Heart Attack Risk

Testosterone replacement therapy has grown into a billion dollar industry and is only expected to continue to thrive in the coming years. As the prescriptions have come pouring in, so have the reports of severe side effects caused by the relatively new medication. While it has long been known that Low-T medications can be harmful to women and children, several more recent studies have shown significant signs that the treatment may be linked to increased risk of heart attack. Studies such as one published in renowned science journal PLoS One have shown compelling evidence that Low T medications such as Androgel may triple the risk of a heart attack in men under 65 within 90 days of starting treatment. Those who have suffered a heart attack while taking the medication are urged to consult a Massachusetts Personal Injury Attorney right away.

There have been so many cases that the FDA is now looking into the safety of Low-T treatment drugs. According to Bloomberg News, the “U.S. Food and Drug Administration said it will re-examine the safety of testosterone replacement drugs after two studies showed a higher risk of heart attacks and strokes in men who use them.” The National Cancer institute conducted a study of 65,000 patients in which both patients older and younger than 65 years of age were twice as likely to suffer a heart attack or other cardiac issues. “When the study compared these men to a separate group of patients taking Viagra and Cialis, the men on the erectile dysfunction drugs patients did not experience more heart attacks,” according to forthepeople.com
The blossoming pharmaceutical industry is feeding on seductive advertisements peddling the drug as a fountain of youth, driving sales and increasing prescriptions for even those with normal testosterone levels. Dr. Steve Nissen, a cardiologist at the Cleveland Clinic, is quoted by CBS News as explaining, “We don’t know very much about this therapy. What’s going on is a giant experiment with American men’s health at stake because we don’t have the long-term data on the safety of these products.”

Five men are already suing Abbott Laboratories and AbbVie Inc for allegedly hiding the dangers associated with their product Androgel. The men claim that the pharmaceutical giant “‘deceived potential AndroGel users by relaying positive information through the press, including testimonials from retired professional athletes’ and statistics suggesting a widespread need for the drugs, ‘while downplaying known adverse and serious health risks,’ according to the complaints,” Bloomberg News reports. The men are all under 65 years old and have suffered from a heart attack, stroke, or “mini stroke.”

Testosterone treatments are sold under numerous different brand names including
• Testim • Androderm • Axiron • Bio-T-Gel • Delatestryl • Dep-Testosterone • Fortesta • Striant • Testopel At the Greater Boston Law Firm of Altman & Altman, LLP, our dedicated team of Massachusetts Personal Injury Attorneys understand the unique difficulties faced by victims of pharmaceutical side effects such as those caused by Low-T treatment. Our attorneys combine the professional expertise of having successfully handled thousands of Personal Injury cases, with the individual attention to understand and respond to the unique nature of your case. We will look into every detail of your case and will explore every legal avenue available in order to deliver legal representation of the highest quality.

At the law offices of Altman & Altman, we are available 24 hours a day, seven days a week – including nights and weekends to answer any questions regarding your case. Call us today to schedule a free initial consultation and case evaluation.

Read more Bloomberg News

Contact Information